Wright Medical Group to Combine Businesses with BioMimetic Therapeutics (BMTI)
Contact Information
Jhonny
Bestotc
5440 W. Sahara Ave., Suite 205
Las Vegas NV, 89146

702 448 1543

** Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. (Nasdaq:BMTI) reported that they have entered into a definitive agreement for a business combination of Wright and BMTI. The transaction will combine BMTI’s breakthrough biologics platform and pipeline with Wrig

Online PR News – 20-November-2012 –BMTI, BioMimetic Therapeutics, Inc.

Wright Medical Group, Inc. and BMTI reported that they have entered into a definitive agreement for a business combination of Wright and BMTI. The transaction will combine BMTI’s breakthrough biologics platform and pipeline with Wright’s established sales force and product portfolio, to further accelerate growth opportunities in Wright’s Extremities business. Under the terms of the agreement, the transaction has a total potential value for BMTI shareholders of approximately $380 million, or $12.97 per share, based on Wright’s closing stock price on Friday, November 16, 2012. The transaction is expected to close in the first quarter of 2013 and is subject to customary closing conditions, including BMTI shareholder approval. BMTI is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for orthopedics, sports medicine and spine applications. More about BMTI at www.biomimetics.com.

Read Full Disclaimer at http://pennyomega.com/disclaimer

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
Copyright 2014 Online PR Media | PO Box 5043 | La Quinta, CA 92248